Silicon Twist

Why investors in Twist's series B think silicon will speed up gene synthesis

Silicon Twist

Investors in Twist Bioscience Corp.'s $26 million series B round expect the company's 10,000-well silicon platform will enable faster, cheaper and more accurate DNA synthesis than traditional 96-well plastic plates.

New

Read the full 310 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE